Investigating how mutations in adrenal cells affect aldosterone production
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
This study is looking at how certain gene changes affect the production of a hormone called aldosterone in people with Primary Aldosteronism, a condition that can cause high blood pressure, to help find better treatment options for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi Med Ctr NIH-funded |
| Lab location | 1 site (Jackson, United States) |
| Project ID | NIH-10447775 on NIH RePORTER |
What this research studies
This research focuses on understanding the complex regulation of aldosterone secretion, particularly in conditions like Primary Aldosteronism (PA), which is a leading cause of secondary hypertension. The study examines how mutations in the ATP1A1 gene, which encodes a sodium/potassium ATPase, influence aldosterone biosynthesis and cell proliferation in adrenal adenomas. By analyzing these mutations, the research aims to clarify their role in excessive aldosterone production, which can lead to serious cardiovascular complications. Patients with PA may benefit from insights gained through this research, potentially leading to improved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Primary Aldosteronism or those with aldosterone-producing adenomas.
Not a fit: Patients without any adrenal disorders or those with essential hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of conditions related to excessive aldosterone production, improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the genetic mutations associated with aldosterone-producing adenomas, indicating that this area of study has potential for significant advancements.
Where this research is happening
Jackson, United States
- University of Mississippi Med Ctr — Jackson, United States (Active)
Researchers
- Principal investigator: Gomez-Sanchez, Celso Enrique — University of Mississippi Med Ctr
- Study coordinator: Gomez-Sanchez, Celso Enrique
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.